| Product Code: ETC10689454 | Publication Date: Apr 2025 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Taiwan Oncology Companion Diagnostics Market Overview |
3.1 Taiwan Country Macro Economic Indicators |
3.2 Taiwan Oncology Companion Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 Taiwan Oncology Companion Diagnostics Market - Industry Life Cycle |
3.4 Taiwan Oncology Companion Diagnostics Market - Porter's Five Forces |
3.5 Taiwan Oncology Companion Diagnostics Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 Taiwan Oncology Companion Diagnostics Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 Taiwan Oncology Companion Diagnostics Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Taiwan Oncology Companion Diagnostics Market Revenues & Volume Share, By Sample Type, 2021 & 2031F |
4 Taiwan Oncology Companion Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Taiwan |
4.2.2 Rising demand for personalized medicine and targeted therapies |
4.2.3 Government initiatives to improve cancer diagnosis and treatment |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for companion diagnostics |
4.3.2 Limited reimbursement policies for companion diagnostics in Taiwan |
5 Taiwan Oncology Companion Diagnostics Market Trends |
6 Taiwan Oncology Companion Diagnostics Market, By Types |
6.1 Taiwan Oncology Companion Diagnostics Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 Taiwan Oncology Companion Diagnostics Market Revenues & Volume, By Technology, 2021 - 2031F |
6.1.3 Taiwan Oncology Companion Diagnostics Market Revenues & Volume, By PCR-Based, 2021 - 2031F |
6.1.4 Taiwan Oncology Companion Diagnostics Market Revenues & Volume, By NGS-Based, 2021 - 2031F |
6.1.5 Taiwan Oncology Companion Diagnostics Market Revenues & Volume, By IHC-Based, 2021 - 2031F |
6.1.6 Taiwan Oncology Companion Diagnostics Market Revenues & Volume, By FISH-Based, 2021 - 2031F |
6.2 Taiwan Oncology Companion Diagnostics Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Taiwan Oncology Companion Diagnostics Market Revenues & Volume, By Lung Cancer, 2021 - 2031F |
6.2.3 Taiwan Oncology Companion Diagnostics Market Revenues & Volume, By Breast Cancer, 2021 - 2031F |
6.2.4 Taiwan Oncology Companion Diagnostics Market Revenues & Volume, By Colorectal Cancer, 2021 - 2031F |
6.2.5 Taiwan Oncology Companion Diagnostics Market Revenues & Volume, By Ovarian Cancer, 2021 - 2031F |
6.3 Taiwan Oncology Companion Diagnostics Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Taiwan Oncology Companion Diagnostics Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Taiwan Oncology Companion Diagnostics Market Revenues & Volume, By Research Centers, 2021 - 2031F |
6.3.4 Taiwan Oncology Companion Diagnostics Market Revenues & Volume, By Diagnostic Labs, 2021 - 2031F |
6.3.5 Taiwan Oncology Companion Diagnostics Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.4 Taiwan Oncology Companion Diagnostics Market, By Sample Type |
6.4.1 Overview and Analysis |
6.4.2 Taiwan Oncology Companion Diagnostics Market Revenues & Volume, By Blood, 2021 - 2031F |
6.4.3 Taiwan Oncology Companion Diagnostics Market Revenues & Volume, By Tissue, 2021 - 2031F |
6.4.4 Taiwan Oncology Companion Diagnostics Market Revenues & Volume, By Saliva, 2021 - 2031F |
6.4.5 Taiwan Oncology Companion Diagnostics Market Revenues & Volume, By Urine, 2021 - 2031F |
7 Taiwan Oncology Companion Diagnostics Market Import-Export Trade Statistics |
7.1 Taiwan Oncology Companion Diagnostics Market Export to Major Countries |
7.2 Taiwan Oncology Companion Diagnostics Market Imports from Major Countries |
8 Taiwan Oncology Companion Diagnostics Market Key Performance Indicators |
8.1 Adoption rate of companion diagnostics by oncologists in Taiwan |
8.2 Number of clinical trials incorporating companion diagnostics in oncology |
8.3 Investment in research and development of new companion diagnostic technologies in Taiwan |
8.4 Number of partnerships between diagnostic companies and pharmaceutical companies for companion diagnostics in Taiwan |
8.5 Rate of integration of companion diagnostics into standard oncology treatment protocols in Taiwan |
9 Taiwan Oncology Companion Diagnostics Market - Opportunity Assessment |
9.1 Taiwan Oncology Companion Diagnostics Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 Taiwan Oncology Companion Diagnostics Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 Taiwan Oncology Companion Diagnostics Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Taiwan Oncology Companion Diagnostics Market Opportunity Assessment, By Sample Type, 2021 & 2031F |
10 Taiwan Oncology Companion Diagnostics Market - Competitive Landscape |
10.1 Taiwan Oncology Companion Diagnostics Market Revenue Share, By Companies, 2024 |
10.2 Taiwan Oncology Companion Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here